Prostate Cancer Incidence and Mortality among Men using Statins and Non-statin Lipid-lowering Medications

BACKGROUND: Statins have demonstrated protection against aggressive/late-stage and/or lethal prostate cancer (PC), but prior studies are limited by small populations, short follow-up, and unequal health care access. Research has not demonstrated that non-statin lipid-lowering medications (NSLLM) pro...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Cancer
Hlavní autoři: Van Rompay, Maria I., Solomon, Keith R., Nickel, J. Curtis, Ranganathan, Gayatri, Kantoff, Philip W., McKinlay, John B.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6501826/
https://ncbi.nlm.nih.gov/pubmed/30850323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2018.11.033
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky